Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 2
1981 2
1982 5
1983 4
1984 2
1985 2
1986 2
1988 4
1989 7
1990 3
1991 6
1992 9
1993 7
1994 4
1995 3
1997 2
1998 1
1999 4
2000 1
2001 5
2002 2
2003 5
2004 2
2005 5
2006 5
2007 4
2008 4
2009 10
2010 5
2011 9
2012 22
2013 20
2014 29
2015 13
2016 6
2017 11
2018 8
2019 9
2020 6
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

228 results
Results by year
Filters applied: . Clear all
Page 1
Whole-genome landscapes of major melanoma subtypes.
Hayward NK, Wilmott JS, Waddell N, Johansson PA, Field MA, Nones K, Patch AM, Kakavand H, Alexandrov LB, Burke H, Jakrot V, Kazakoff S, Holmes O, Leonard C, Sabarinathan R, Mularoni L, Wood S, Xu Q, Waddell N, Tembe V, Pupo GM, De Paoli-Iseppi R, Vilain RE, Shang P, Lau LMS, Dagg RA, Schramm SJ, Pritchard A, Dutton-Regester K, Newell F, Fitzgerald A, Shang CA, Grimmond SM, Pickett HA, Yang JY, Stretch JR, Behren A, Kefford RF, Hersey P, Long GV, Cebon J, Shackleton M, Spillane AJ, Saw RPM, López-Bigas N, Pearson JV, Thompson JF, Scolyer RA, Mann GJ. Hayward NK, et al. Among authors: kefford rf. Nature. 2017 May 11;545(7653):175-180. doi: 10.1038/nature22071. Epub 2017 May 3. Nature. 2017. PMID: 28467829
Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy.
Shi H, Hugo W, Kong X, Hong A, Koya RC, Moriceau G, Chodon T, Guo R, Johnson DB, Dahlman KB, Kelley MC, Kefford RF, Chmielowski B, Glaspy JA, Sosman JA, van Baren N, Long GV, Ribas A, Lo RS. Shi H, et al. Among authors: kefford rf. Cancer Discov. 2014 Jan;4(1):80-93. doi: 10.1158/2159-8290.CD-13-0642. Epub 2013 Nov 21. Cancer Discov. 2014. PMID: 24265155 Free PMC article.
Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations.
Flaherty KT, Infante JR, Daud A, Gonzalez R, Kefford RF, Sosman J, Hamid O, Schuchter L, Cebon J, Ibrahim N, Kudchadkar R, Burris HA 3rd, Falchook G, Algazi A, Lewis K, Long GV, Puzanov I, Lebowitz P, Singh A, Little S, Sun P, Allred A, Ouellet D, Kim KB, Patel K, Weber J. Flaherty KT, et al. Among authors: kefford rf. N Engl J Med. 2012 Nov 1;367(18):1694-703. doi: 10.1056/NEJMoa1210093. Epub 2012 Sep 29. N Engl J Med. 2012. PMID: 23020132 Free PMC article. Clinical Trial.
Oncogenic signaling in uveal melanoma.
Park JJ, Diefenbach RJ, Joshua AM, Kefford RF, Carlino MS, Rizos H. Park JJ, et al. Among authors: kefford rf. Pigment Cell Melanoma Res. 2018 Nov;31(6):661-672. doi: 10.1111/pcmr.12708. Epub 2018 May 23. Pigment Cell Melanoma Res. 2018. PMID: 29738114 Review.
Cutaneous melanoma.
Thompson JF, Scolyer RA, Kefford RF. Thompson JF, et al. Among authors: kefford rf. Lancet. 2005 Feb 19-25;365(9460):687-701. doi: 10.1016/S0140-6736(05)17951-3. Lancet. 2005. PMID: 15721476 Review.
Liquid biomarkers in melanoma: detection and discovery.
Lim SY, Lee JH, Diefenbach RJ, Kefford RF, Rizos H. Lim SY, et al. Among authors: kefford rf. Mol Cancer. 2018 Jan 17;17(1):8. doi: 10.1186/s12943-018-0757-5. Mol Cancer. 2018. PMID: 29343260 Free PMC article. Review.
The ARF tumour suppressor.
Gallagher SJ, Kefford RF, Rizos H. Gallagher SJ, et al. Among authors: kefford rf. Int J Biochem Cell Biol. 2006;38(10):1637-41. doi: 10.1016/j.biocel.2006.02.008. Epub 2006 Feb 28. Int J Biochem Cell Biol. 2006. PMID: 16600663 Review.
228 results